
Signal over Noise with Ulrike Hoffmann-Burchardi
UBS On-Air: Market Moves
00:00
Pfizer deal signals pharma re-rating and onshore investment
Ulrike describes the US-Pfizer agreement linking tariff relief to lower drug prices and $500bn pharma CapEx, reducing uncertainty and prompting sector re-rating.
Play episode from 01:30
Transcript


